• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Teva abandons Ajovy trial for cluster headaches pharmatimes
    April 24, 2019
    Teva has announced an update on its Ajovy (fremanezumab) clinical development for use in episodic cluster headache, after a Phase III study found that the primary endpoint for weekly average number of cluster headache attacks during the four-week treatmen
  • FDA Approves Device to Help Curb Cluster Headaches drugs.com
    April 20, 2017
    Cluster headaches, though rare, are among the most severe forms of headache a person can face.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service